1. NAMPT enhances LOX expression and promotes metastasis in human chondrosarcoma cells by inhibiting miR‐26b‐5p synthesis.
- Author
-
Lin, Chih‐Yang, Law, Yat‐Yin, Yu, Cheng‐Chieh, Wu, Yu‐Ying, Hou, Sheng‐Mou, Chen, Wei‐Li, Yang, Shang‐Yu, Tsai, Chun‐Hao, Lo, Yuan‐Shun, Fong, Yi‐Chin, and Tang, Chih‐Hsin
- Subjects
LYSYL oxidase ,CHONDROSARCOMA ,GENE expression ,CELL migration ,METASTASIS ,LUNGS - Abstract
Chondrosarcoma is a malignant bone tumor that emerges from abnormalities in cartilaginous tissue and is related with lung metastases. Nicotinamide phosphoribosyltransferase (NAMPT) is an adipocytokine reported to enhance tumor metastasis. Our results from clinical samples and the Gene Expression Omnibus data set reveal that NAMPT levels are markedly higher in chondrosarcoma patients than in normal individuals. NAMPT stimulation significantly increased lysyl oxidase (LOX) production in chondrosarcoma cells. Additionally, NAMPT increased LOX‐dependent cell migration and invasion in chondrosarcoma by suppressing miR‐26b‐5p generation through the c‐Src and Akt signaling pathways. Overexpression of NAMPT promoted chondrosarcoma metastasis to the lung in vivo. Furthermore, knockdown of LOX counteracted NAMPT‐facilitated metastasis. Thus, the NAMPT/LOX axis presents a novel target for treating the metastasis of chondrosarcoma. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF